Asymmetry Capital Management, L.P. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,511,000
-55.6%
62,507
-12.8%
2.71%
-52.4%
Q1 2019$3,405,000
+64.1%
71,675
+24.7%
5.69%
-0.8%
Q4 2018$2,075,000
-53.8%
57,486
-21.2%
5.73%
+38.2%
Q3 2018$4,491,000
+33.6%
72,970
+46.7%
4.15%
+25.6%
Q2 2018$3,361,000
-11.1%
49,756
-28.6%
3.30%
-30.1%
Q1 2018$3,780,000
+56.8%
69,676
+72.8%
4.73%
+44.5%
Q4 2017$2,410,000
+175.7%
40,330
+124.4%
3.27%
+222.6%
Q3 2017$874,000
-34.7%
17,975
-29.4%
1.01%
-36.1%
Q2 2017$1,338,000
-39.5%
25,464
-47.8%
1.59%
-48.6%
Q1 2017$2,213,000
-8.8%
48,800
-23.9%
3.08%
-31.6%
Q4 2016$2,426,000
-57.3%
64,095
-57.5%
4.51%
-54.4%
Q3 2016$5,686,000
+284.4%
150,651
+79.3%
9.89%
+265.0%
Q2 2016$1,479,000
-13.5%
84,026
-40.2%
2.71%
-39.2%
Q1 2016$1,710,000
-18.3%
140,587
+63.7%
4.46%
+40.9%
Q4 2015$2,092,000
+37.4%
85,895
+0.1%
3.16%
-6.8%
Q3 2015$1,523,00085,8343.39%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,464,749$98,944,00034.86%
Foresite Capital Management III, LLC 1,708,046$115,379,00024.85%
Eversept Partners, LP 226,902$15,327,2307.01%
SECTORAL ASSET MANAGEMENT INC 615,870$41,602,0004.65%
DAFNA Capital Management LLC 131,770$8,901,0004.17%
PACIFIC VIEW ASSET MANAGEMENT, LLC 68,666$4,638,0003.67%
Asymmetry Capital Management, L.P. 49,756$3,361,0003.30%
PFM Health Sciences, LP 2,720,218$183,751,0002.88%
HealthCor Management, L.P. 1,314,290$88,780,0002.82%
Boulegeris Investments, Inc. 66,540$4,495,0002.25%
View complete list of AERIE PHARMACEUTICALS INC shareholders